简体中文
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#sclerodermaforum 搜索结果

未找到 "#sclerodermaforum" 的结果
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年12月1日

Looking for the latest insights in #scleroderma? Our new slide deck and literature highlights are live on the #SclerodermaForum. Access these valuable resources today: 🔗ow.ly/iAxi50XrF53

ScleroForum's tweet image. Looking for the latest insights in #scleroderma? Our new slide deck and literature highlights are live on the #SclerodermaForum. Access these valuable resources today: 🔗ow.ly/iAxi50XrF53
0
0
0
0
34
未找到 "#sclerodermaforum" 的结果
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年11月14日

Our latest #scleroderma slide deck and literature highlights are now available on the #SclerodermaForum! Stay up to date with the newest research and clinical insights. Access them for free today: 🔗ow.ly/lVvn50XrEVV

ScleroForum's tweet image. Our latest #scleroderma slide deck and literature highlights are now available on the #SclerodermaForum! Stay up to date with the newest research and clinical insights. Access them for free today: 🔗ow.ly/lVvn50XrEVV
0
0
1
0
40
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年10月22日

📑Our latest #scleroderma literature highlights, featuring research by Chung et al., are now live on the #SclerodermaForum. 👉Access these comprehensive slide decks for the latest insights in #scleroderma treatment: ow.ly/ISHJ50WYOch

ScleroForum's tweet image. 📑Our latest #scleroderma literature highlights, featuring research by Chung et al., are now live on the #SclerodermaForum. 👉Access these comprehensive slide decks for the latest insights in #scleroderma treatment: ow.ly/ISHJ50WYOch
0
0
1
0
59
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年8月5日

In patients with dcSSc, safety, PK and bioavailability profiles of IgPro20, and safety and PK of IgPro10, are similar to those observed in other approved indications, as shown by Denton et al. 👀See the full insights from the #SclerodermaForum: ow.ly/Fbxf50WnvRm

ScleroForum's tweet image. In patients with dcSSc, safety, PK and bioavailability profiles of IgPro20, and safety and PK of IgPro10, are similar to those observed in other approved indications, as shown by Denton et al. 👀See the full insights from the #SclerodermaForum: ow.ly/Fbxf50WnvRm
0
0
0
0
39
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年11月25日

Dive into the latest research on #scleroderma with our new in-depth slide deck and literature highlights! Available now for free on the #SclerodermaForum: 🔗ow.ly/SUHJ50XrF3M

ScleroForum's tweet image. Dive into the latest research on #scleroderma with our new in-depth slide deck and literature highlights! Available now for free on the #SclerodermaForum: 🔗ow.ly/SUHJ50XrF3M
0
0
1
0
46
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年10月14日

🔎 Discover the newest findings in #scleroderma in our latest literature highlights. Enhance your clinical knowledge with free access on the #SclerodermaForum: ow.ly/1URA50WYO7G

ScleroForum's tweet image. 🔎 Discover the newest findings in #scleroderma in our latest literature highlights. Enhance your clinical knowledge with free access on the #SclerodermaForum: ow.ly/1URA50WYO7G
0
0
0
0
37
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年10月6日

⭐ Enhance your understanding of #scleroderma with our newly uploaded slide deck and literature highlights. Visit the #SclerodermaForum today to access these free resources: ow.ly/KfY150WYO5E

ScleroForum's tweet image. ⭐ Enhance your understanding of #scleroderma with our newly uploaded slide deck and literature highlights. Visit the #SclerodermaForum today to access these free resources: ow.ly/KfY150WYO5E
0
0
1
0
38
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年10月2日

📣 Stay informed with our latest #scleroderma literature highlights and detailed slide decks. Now available for free on the #SclerodermaForum: ow.ly/LWs150WYO4Z

ScleroForum's tweet image. 📣 Stay informed with our latest #scleroderma literature highlights and detailed slide decks. Now available for free on the #SclerodermaForum: ow.ly/LWs150WYO4Z
0
0
0
0
27
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年9月24日

👀Looking for the latest insights in #scleroderma? Our new slide deck and literature highlights are live on the #SclerodermaForum. 🔗Access these valuable resources today: ow.ly/wW5E50WYNWR

ScleroForum's tweet image. 👀Looking for the latest insights in #scleroderma? Our new slide deck and literature highlights are live on the #SclerodermaForum. 🔗Access these valuable resources today: ow.ly/wW5E50WYNWR
0
0
0
0
29
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年8月1日

This target trial emulation used real-world data from 208 matched patients with early dcSSc. Both treatment strategies—immunosuppression alone or with GCs—led to similar skin score improvements. 👀See full insights from Mongin et al. #SclerodermaForum scleroderma-forum.com/literature-rev…

ScleroForum's tweet image. This target trial emulation used real-world data from 208 matched patients with early dcSSc. Both treatment strategies—immunosuppression alone or with GCs—led to similar skin score improvements. 👀See full insights from Mongin et al. #SclerodermaForum scleroderma-forum.com/literature-rev…
0
0
0
0
33
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年7月29日

👉 #SclerodermaForum is featured in The Scleroderma Research Foundation (#SRF) July eNewsletter. Read the newsletter here 🔗ow.ly/nzT550Wu2Za

ScleroForum's tweet image. 👉 #SclerodermaForum is featured in The Scleroderma Research Foundation (#SRF) July eNewsletter. Read the newsletter here 🔗ow.ly/nzT550Wu2Za
0
0
1
0
61
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年7月30日

The Scleroderma Research Foundation (#SRF) featured #SclerodermaForum in its July eNewsletter. 🗞️ Access the newsletter today. 🔗ow.ly/lUx450Wu36Y

ScleroForum's tweet image. The Scleroderma Research Foundation (#SRF) featured #SclerodermaForum in its July eNewsletter. 🗞️ Access the newsletter today. 🔗ow.ly/lUx450Wu36Y
0
0
1
0
58
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年8月4日

Enhance your understanding of #Scleroderma with our newly uploaded slide decks and literature highlights. 👉Visit the #SclerodermaForum today to access these free resources: ow.ly/tlCj50Wnw0U

ScleroForum's tweet image. Enhance your understanding of #Scleroderma with our newly uploaded slide decks and literature highlights. 👉Visit the #SclerodermaForum today to access these free resources: ow.ly/tlCj50Wnw0U
0
0
1
0
49
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年12月1日

Looking for the latest insights in #scleroderma? Our new slide deck and literature highlights are live on the #SclerodermaForum. Access these valuable resources today: 🔗ow.ly/iAxi50XrF53

ScleroForum's tweet image. Looking for the latest insights in #scleroderma? Our new slide deck and literature highlights are live on the #SclerodermaForum. Access these valuable resources today: 🔗ow.ly/iAxi50XrF53
0
0
0
0
34
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年7月31日

After the successful launch of #SclerodermaForum at this year’s #EULAR, The Scleroderma Research Foundation (#SRF) has featured us in their July eNewsletter. 📧 Access the newsletter 🔗ow.ly/NliR50Wu3cG

ScleroForum's tweet image. After the successful launch of #SclerodermaForum at this year’s #EULAR, The Scleroderma Research Foundation (#SRF) has featured us in their July eNewsletter. 📧 Access the newsletter 🔗ow.ly/NliR50Wu3cG
0
0
0
0
67
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年7月24日

🌟Following last month’s launch at #EULAR, #SclerodermaForum is featured in the July eNewsletter from The Scleroderma Research Foundation (#SRF). Visit the newsletter today 🔗ow.ly/lS6T50Wu2Ug

ScleroForum's tweet image. 🌟Following last month’s launch at #EULAR, #SclerodermaForum is featured in the July eNewsletter from The Scleroderma Research Foundation (#SRF). Visit the newsletter today 🔗ow.ly/lS6T50Wu2Ug
0
0
1
0
69
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年8月8日

The ReSScue trial provides valuable insights that can inform future GIT studies in patients with systemic sclerosis, as shown by Fretheim et al. 👀See the full insights from the #SclerodermaForum: ow.ly/hm7A50WnvS8

ScleroForum's tweet image. The ReSScue trial provides valuable insights that can inform future GIT studies in patients with systemic sclerosis, as shown by Fretheim et al. 👀See the full insights from the #SclerodermaForum: ow.ly/hm7A50WnvS8
0
0
0
0
41
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年7月25日

Denton et al. report that weekly SC immunoglobulin and monthly IV immunoglobulin were well-tolerated in patients with systemic sclerosis. No new safety concerns were observed. 👇👇 ow.ly/3IW450WnvNI #SclerodermaForum

ScleroForum's tweet image. Denton et al. report that weekly SC immunoglobulin and monthly IV immunoglobulin were well-tolerated in patients with systemic sclerosis. No new safety concerns were observed. 👇👇 ow.ly/3IW450WnvNI #SclerodermaForum
0
0
0
0
35
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年7月28日

In systemic sclerosis patients, Fretheim et al. observed that the safety profile of faecal microbiota transplantation with ACHIM was comparable to that of placebo. 👀Learn more here: ow.ly/SOLt50WnvOh #SclerodermaForum

ScleroForum's tweet image. In systemic sclerosis patients, Fretheim et al. observed that the safety profile of faecal microbiota transplantation with ACHIM was comparable to that of placebo. 👀Learn more here: ow.ly/SOLt50WnvOh #SclerodermaForum
0
0
0
0
26
ScleroForum's profile picture. Providing medical education to clinicians around the globe to facilitate greater understanding of scleroderma, its treatments, and clinical practice.
Scleroderma Forum
@ScleroForum
年7月24日

Fretheim et al. report that 48% of systemic sclerosis patients receiving faecal microbiota transplantation with ACHIM experienced adverse events, mostly mild and short-lived gastrointestinal tract symptoms. 👂Learn more on the #SclerodermaForum: ow.ly/UgEY50WnvMY

ScleroForum's tweet image. Fretheim et al. report that 48% of systemic sclerosis patients receiving faecal microbiota transplantation with ACHIM experienced adverse events, mostly mild and short-lived gastrointestinal tract symptoms. 👂Learn more on the #SclerodermaForum: ow.ly/UgEY50WnvMY
0
0
1
0
32

Something went wrong.


Something went wrong.


United States Trends